FDA Corrects Notice on Withdrawal of 24 Abbreviated New Drug Applications

Summary

The Food and Drug Administration (FDA) is correcting a notice that announced the voluntary withdrawal of approval of 24 abbreviated new drug applications (ANDAs) from multiple applicants, including Sun Pharmaceutical Industries, Ltd. The correction comes after Sun Pharmaceutical requested that the FDA not withdraw approval of a specific ANDA, resulting in the approval remaining in effect.